Ingredients for foods, drinks, household goods and personal care products are what International Flavors and Fragrances develops and manufactures. Its work covers flavours and taste solutions, fragrance and scent ingredients, food ingredients such as texturants and proteins, and health and biosciences products including enzymes and probiotics. Customers are consumer goods and food and beverage manufacturers, which use its ingredients in their own branded products.
Revenue of $10.0 billion over the last twelve months comes from creating ingredients and compounds to customer specifications and supplying them in volume. Revenue has changed at -4.3% a year across the last three years. The operating margin is 7.6%, the business earns 3% on the capital invested in it, and net debt is 3.3 times EBITDA. The dividend yield is 1.8%. On the site's X-Ray Score it receives 23 out of 100.
Written with AI from public information and the filing figures on this page, then checked automatically for unsupported numbers. It can contain mistakes: read the company's own filings below before relying on it.
52-wk range $59.97 – $91.88Volume 2,247,700Daily, split-adjusted
Vitals
Market cap$23.3B
52-week range$59.97 – $91.88
Volume (last day)2,247,700
P/E (TTM)79.7
EBIT / EV yield2.6%
Free-cash-flow yield2.3%
Dividend yield1.8%
Revenue (TTM)$10.0B
Net income (TTM)$292M
Operating margin7.6%
Return on capital3.0%
Debt incl. leases$6.2B
Cash & securities$569M
Debt = borrowings plus lease liabilities. Cash & securities = cash, equivalents and short-term marketable securities (long-term securities are not counted, so net cash can be understated for companies like Apple). Net debt = debt minus cash & securities. Source: latest SEC 10-Q/10-K. EBIT / EV yield = operating profit divided by market cap plus net debt.
Fair value estimate
$11model spread $11 – $11
Data under review+0.0% to fair value
Equal blend of three models: peer multiples, a fundamentals-adjusted multiple (growth, ROIC and margin) and a 10-year DCF scaled to the market's average. Earnings-power value (no growth) is a floor and not part of the blend. Model uncertainty is High, so the safety margin is 40%.
Multiples use through-the-cycle earnings (0.30x of the last twelve months)
Peak-cycle earnings: the current operating margin is more than 1.5x its 7-year average, so the fair value range is widened
Earnings are far above the company's own 3-year history, so models would extrapolate a possible peak
Price $91
Undervalued < $7Fair $7 – $15Overvalued > $15
10-year DCF (market-scaled)
$-36
Peer multiples
$12
Earnings power floor (not blended)
$-21
Fundamentals-adjusted multiple
$10
A model estimate, not a price target or recommendation. Inputs: risk-free 5.09%, equity risk premium 4.23% (Damodaran). How it works.
What this means
Read the lenses below
The price sits inside our fair-value band. A high score does not guarantee a good outcome; it shifts the odds a little. Use the checklist as a prompt for your own research.
Before you invest · decision checklist
Ticked boxes are filled in from our data; the rest are yours to answer.
The five-lens scan
Every score explained in one sentence, ranked against Materials peers. Open a lens to see the numbers behind it.
ValuationWeak
14/100
Expensive against its sector on earnings and cash flow.
See the numbers →
EBIT / EV yield2.6%
Free-cash-flow yield2.3%
Fair value vs price0.1×
GrowthWeak
15/100
Growing slower than most of its sector.
See the numbers →
Revenue growth (3y)-4.3%
Growth consistency30%
ProfitabilityWeak
30/100
Earns lower returns on its capital than most peers.
See the numbers →
Return on invested capital3.0%
Operating margin7.6%
Gross profitability14.9%
Financial healthWeak
35/100
Balance sheet is more stretched than most peers.
See the numbers →
Piotroski F-Score6 / 9
Net debt / EBITDA3.3×
Interest cover4.0×
DividendsWeak
22/100
Dividend is modest or less certain than peers.
See the numbers →
Dividend yield1.8%
Dividends vs free cash flow76%
Dividend growth-20.4%
Quarterly results: last 6 quarters
-1.9%Mar '25
-33.6%Jun '25
-7.9%Sep '25
-6.6%Dec '25
-3.6%Mar '26
+1.8%Jun '26
Revenue against the same quarter a year earlier. Latest quarter revenue $2.0B, diluted EPS $0.20.
Other Specialty Chemicals companies by X-Ray Score.
Fundamentals checklist
● 0 Good · ● 4 Average · ● 10 Bad
Cash quality
Earnings backed by cashAverage
Free-cash-flow yieldBad
Risk models
Altman Z''Bad
Piotroski F-ScoreAverage
Growth
Revenue growth (3y)Bad
Growth consistencyBad
Balance sheet
Current ratioAverage
Net debt / EBITDABad
Interest coverBad
Valuation
Fair value vs priceBad
EBIT / EV yieldBad
Profitability
Return on invested capitalBad
Operating marginBad
Gross profitabilityAverage
Each check is graded against the company's sector, not a fixed number. Checklist score 27/100.
Financials
FY21
FY22
FY23
FY24
FY25
Revenue
$11.7B
$12.4B
$11.5B
$11.5B
$10.9B
Operating income
$585M
−$1.3B
−$2.1B
$766M
−$382M
Net income
$279M
−$1.9B
−$2.6B
$267M
−$359M
Operating cash flow
$1.4B
$397M
$1.5B
$1.1B
$850M
Operating margin
5.0%
-10.7%
-18.4%
6.7%
-3.5%
Free cash flow
$1.0B
−$107M
$952M
$607M
$256M
Diluted EPS
$1.10
$-7.32
$-10.14
$1.04
$-1.41
Fiscal years, from SEC filings.
Technical summary
Daily
Bullish
12 bullish · 0 neutral · 4 bearish
Weekly
Strongly bullish
11 bullish · 1 neutral · 0 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
86.42
Bullish
EMA 10
87.40
Bullish
SMA 20
85.54
Bullish
EMA 20
86.13
Bullish
SMA 50
84.91
Bullish
EMA 50
84.28
Bullish
SMA 100
80.94
Bullish
EMA 100
81.54
Bullish
SMA 200
76.69
Bullish
EMA 200
78.05
Bullish
Oscillators (daily)
RSI (14)
73.73
Bearish
MACD (12, 26)
1.32
Bullish
Momentum (12)
8.62
Bullish
Stochastic %K (14)
88.39
Bearish
Williams %R (14)
-11.61
Bearish
CCI (20)
208.0
Bearish
Pivot points (classic, last session)
S3
87.50
S2
88.61
S1
89.65
Pivot
90.76
R1
91.80
R2
92.91
R3
93.95
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
1.60 USD
Yield on today's price
1.76%
Frequency
Quarterly
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
18 Sep 2026
0.4000
18 Jun 2026
0.4000
20 Mar 2026
0.4000
19 Dec 2025
0.4000
29 Sep 2025
0.4000
20 Jun 2025
0.4000
21 Mar 2025
0.4000
20 Dec 2024
0.4000
20 Sep 2024
0.4000
21 Jun 2024
0.4000
21 Mar 2024
0.4000
27 Dec 2023
0.8100
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.